U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: December 18 - December 24, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: December 18 - December 24, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 12/19/2022
Location: Virtual
Subject: Discussion of the Independent Panel of Experts Report on FDA's Tobacco Program
FDA Participant/Group: JAMES FLAHIVE; TRISTAN COLONIUS;
Non FDA Participant/Group: Matthew Myers (Campaign for Tobacco Free Kids);

Event Date: 12/19/2022
Location: Virtual
Subject: Discussion of the Independent Panel of Experts Report on FDA's Tobacco Program
FDA Participant/Group: JAMES FLAHIVE; JULIA TIERNEY; TRISTAN COLONIUS;
Non FDA Participant/Group: Harold Wimmer (American Lung Association);

Event Date: 12/19/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: JULIA TIERNEY; MICHELLE ADAMS;
Non FDA Participant/Group: Chip Davis, Liz Gallenagh, Nicolette Louissaint, Patrick Kelly (Healthcare Distribution Alliance);

Event Date: 12/20/2022
Location: Virtual
Subject: Misinformation
FDA Participant/Group: NAMANDJE BUMPUS; ERICA JEFFERSON; HILARY MARSTON;
Non FDA Participant/Group: Amar Bhat, Carolyn Hiller, Susan Winckler (Regan Udall Foundation); Elaine Arkin (FHI 360); Reed Tuckson (Tuckson Health Connections LLC); Julie Gerberding (Foundation for the National Institutes of Health);

Event Date: 12/20/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: MICHELLE ADAMS; JULIA TIERNEY;
Non FDA Participant/Group: Murray Kessler (Perrigo); Stephen Cha, Xavier Becerra (U.S. Department of Health and Human Services);

Event Date: 12/20/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: JULIA TIERNEY; MICHELLE ADAMS;
Non FDA Participant/Group: Stephen Cha, Xavier Becerra (U.S. Department of Health and Human Services); Scott Melville (Consumer Healthcare Products Association);

Event Date: 12/20/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: MICHELLE ADAMS; JULIA TIERNEY;
Non FDA Participant/Group: Christopher Fetzer, Jeff Gramm, Linda Robbins, Patrick Cashman (USAntibiotics); Stephen Cha, Xavier Becerra (U.S. Department of Health and Human Services);

Event Date: 12/20/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: JULIA TIERNEY; MICHELLE ADAMS;
Non FDA Participant/Group: Caroline Tillett, Donna Lorenson, Glen Murphy, Joanne Waldstreicher, Kathy Widmer, Meri Stevens (Johnson & Johnson); Stephen Cha, Xavier Becerra (U.S. Department of Health and Human Services);

Event Date: 12/21/2022
Location: Virtual
Subject: Discussion of the Independent Panel of Experts Report on FDA's Tobacco Program
FDA Participant/Group: EMILY HELMS WILLIAMS;
Non FDA Participant/Group: Karen Collishaw (American Thoracic Society);

Event Date: 12/22/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Dereck Naten, Sigurdur Olafsson, Stephen Welch (Mallinckrodt Pharmaceuticals);

Event Date: 12/23/2022
Location: Virtual
Subject: Discussion of the Independent Panel of Experts Report on FDA's Tobacco Program
FDA Participant/Group: JAMES FLAHIVE;
Non FDA Participant/Group: Nancy Brown (American Heart Association);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 

Back to Top